Received Jun 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TD | TD ADSORBED (TENIVAC) | SANOFI PASTEUR | UNK | U8207AC | IM / LA |
Patient received and expired TENIVAC vaccine with no adverse event; Initial information received on 15-Jun-2026 regarding an unsolicited valid non-serious case received from a health care professional. This case involves a female patient of unknown age who received and expired diphtheria toxoid/tetanus toxoid (TENIVAC) with no adverse event. The patient's past medical history, past drugs, vaccination(s), family history, and concomitant medications were not provided. On 11-Jun-2026, the patient received expired diphtheria toxoid/tetanus toxoid (TENIVAC), suspension for injection, at a dose of 0.5 mL, 1X (dose 2, U8207AC; expiry date: 31-May-2026), intramuscular route in Left Deltoid for immunization with no adverse event (expired product administered) (latency same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.